The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Allergy Immunotherapy Market Research Report 2025
Synopsis
The global market for Allergy Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapy.
The Allergy Immunotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allergy Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Immunotherapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Others
Consumption by Region
North America
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allergy Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
The global market for Allergy Immunotherapy was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
Allergen immunotherapy, also known as desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system"s response.
The primary therapeutic goals of allergy immunotherapy (AIT) include reducing symptoms, reducing symptomatic medication use, and improving allergyrelated quality of life. The evidence is strong that AIT achieves these goals and can alter the course of the disease, with benefits persisting in many patients for several years after treatment discontinuation.
In EMEA, Allergy Immunotherapy main players include ALK-Abello, Stallergenes Greer, Merck, Allergy Therapeutics, HAL, Holister Stier, Leti, etc., totally accounting for about 98% of market. As for the types of products, it can be divided into Subcutaneous Immunotherapy and Sublingual Immunotherapy. The most common product is Subcutaneous Immunotherapy, with a share over 60%. In terms of applications, it is widely used in Allergic Rhinitis, Allergic Asthma and Others. The most application is in Allergic Rhinitis, with a share over 45%.
Report Scope
This report aims to provide a comprehensive presentation of the global market for Allergy Immunotherapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Allergy Immunotherapy.
The Allergy Immunotherapy market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Allergy Immunotherapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Allergy Immunotherapy manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
By Company
ALK-Abello
Stallergenes Greer
Merck
Allergy Therapeutics
HAL
Holister Stier
Leti
Segment by Type
Subcutaneous Immunotherapy
Sublingual Immunotherapy
Segment by Application
Allergic Rhinitis
Allergic Asthma
Others
Consumption by Region
North America
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Europe
Germany
France
U.K.
Italy
Russia
Latin America
Mexico
Brazil
Argentina
Middle East and Africa
Turkey
Saudi Arabia
UAE
Core Chapters
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Detailed analysis of Allergy Immunotherapy manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 3: Sales, revenue of Allergy Immunotherapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 9: The main points and conclusions of the report.
Index1 Allergy Immunotherapy Market Overview
1.1 Product Definition
1.2 Allergy Immunotherapy by Type
1.2.1 Global Allergy Immunotherapy Market Value Comparison by Type (2024 VS 2031)
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Allergy Immunotherapy by Application
1.3.1 Global Allergy Immunotherapy Market Value by Application (2024 VS 2031)
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Others
1.4 Global Allergy Immunotherapy Market Size Estimates and Forecasts
1.4.1 Global Allergy Immunotherapy Revenue 2020-2031
1.4.2 Global Allergy Immunotherapy Sales 2020-2031
1.4.3 Global Allergy Immunotherapy Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Allergy Immunotherapy Market Competition by Manufacturers
2.1 Global Allergy Immunotherapy Sales Market Share by Manufacturers (2020-2025)
2.2 Global Allergy Immunotherapy Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Allergy Immunotherapy Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Allergy Immunotherapy, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Allergy Immunotherapy, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Allergy Immunotherapy, Product Type & Application
2.7 Global Key Manufacturers of Allergy Immunotherapy, Date of Enter into This Industry
2.8 Global Allergy Immunotherapy Market Competitive Situation and Trends
2.8.1 Global Allergy Immunotherapy Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Allergy Immunotherapy Players Market Share by Revenue
2.8.3 Global Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Allergy Immunotherapy Market Scenario by Region
3.1 Global Allergy Immunotherapy Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Allergy Immunotherapy Sales by Region: 2020-2031
3.2.1 Global Allergy Immunotherapy Sales by Region: 2020-2025
3.2.2 Global Allergy Immunotherapy Sales by Region: 2026-2031
3.3 Global Allergy Immunotherapy Revenue by Region: 2020-2031
3.3.1 Global Allergy Immunotherapy Revenue by Region: 2020-2025
3.3.2 Global Allergy Immunotherapy Revenue by Region: 2026-2031
3.4 North America Allergy Immunotherapy Market Facts & Figures by Country
3.4.1 North America Allergy Immunotherapy Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Allergy Immunotherapy Sales by Country (2020-2031)
3.4.3 North America Allergy Immunotherapy Revenue by Country (2020-2031)
3.5 Europe Allergy Immunotherapy Market Facts & Figures by Country
3.5.1 Europe Allergy Immunotherapy Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Allergy Immunotherapy Sales by Country (2020-2031)
3.5.3 Europe Allergy Immunotherapy Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Allergy Immunotherapy Market Facts & Figures by Region
3.6.1 Asia Pacific Allergy Immunotherapy Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Allergy Immunotherapy Sales by Region (2020-2031)
3.6.3 Asia Pacific Allergy Immunotherapy Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Allergy Immunotherapy Market Facts & Figures by Country
3.7.1 Latin America Allergy Immunotherapy Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Allergy Immunotherapy Sales by Country (2020-2031)
3.7.3 Latin America Allergy Immunotherapy Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Allergy Immunotherapy Market Facts & Figures by Country
3.8.1 Middle East and Africa Allergy Immunotherapy Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Allergy Immunotherapy Sales by Country (2020-2031)
3.8.3 Middle East and Africa Allergy Immunotherapy Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Allergy Immunotherapy Sales by Type (2020-2031)
4.1.1 Global Allergy Immunotherapy Sales by Type (2020-2025)
4.1.2 Global Allergy Immunotherapy Sales by Type (2026-2031)
4.1.3 Global Allergy Immunotherapy Sales Market Share by Type (2020-2031)
4.2 Global Allergy Immunotherapy Revenue by Type (2020-2031)
4.2.1 Global Allergy Immunotherapy Revenue by Type (2020-2025)
4.2.2 Global Allergy Immunotherapy Revenue by Type (2026-2031)
4.2.3 Global Allergy Immunotherapy Revenue Market Share by Type (2020-2031)
4.3 Global Allergy Immunotherapy Price by Type (2020-2031)
5 Segment by Application
5.1 Global Allergy Immunotherapy Sales by Application (2020-2031)
5.1.1 Global Allergy Immunotherapy Sales by Application (2020-2025)
5.1.2 Global Allergy Immunotherapy Sales by Application (2026-2031)
5.1.3 Global Allergy Immunotherapy Sales Market Share by Application (2020-2031)
5.2 Global Allergy Immunotherapy Revenue by Application (2020-2031)
5.2.1 Global Allergy Immunotherapy Revenue by Application (2020-2025)
5.2.2 Global Allergy Immunotherapy Revenue by Application (2026-2031)
5.2.3 Global Allergy Immunotherapy Revenue Market Share by Application (2020-2031)
5.3 Global Allergy Immunotherapy Price by Application (2020-2031)
6 Key Companies Profiled
6.1 ALK-Abello
6.1.1 ALK-Abello Company Information
6.1.2 ALK-Abello Description and Business Overview
6.1.3 ALK-Abello Allergy Immunotherapy Sales, Revenue and Gross Margin (2020-2025)
6.1.4 ALK-Abello Allergy Immunotherapy Product Portfolio
6.1.5 ALK-Abello Recent Developments/Updates
6.2 Stallergenes Greer
6.2.1 Stallergenes Greer Company Information
6.2.2 Stallergenes Greer Description and Business Overview
6.2.3 Stallergenes Greer Allergy Immunotherapy Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Stallergenes Greer Allergy Immunotherapy Product Portfolio
6.2.5 Stallergenes Greer Recent Developments/Updates
6.3 Merck
6.3.1 Merck Company Information
6.3.2 Merck Description and Business Overview
6.3.3 Merck Allergy Immunotherapy Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Merck Allergy Immunotherapy Product Portfolio
6.3.5 Merck Recent Developments/Updates
6.4 Allergy Therapeutics
6.4.1 Allergy Therapeutics Company Information
6.4.2 Allergy Therapeutics Description and Business Overview
6.4.3 Allergy Therapeutics Allergy Immunotherapy Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Allergy Therapeutics Allergy Immunotherapy Product Portfolio
6.4.5 Allergy Therapeutics Recent Developments/Updates
6.5 HAL
6.5.1 HAL Company Information
6.5.2 HAL Description and Business Overview
6.5.3 HAL Allergy Immunotherapy Sales, Revenue and Gross Margin (2020-2025)
6.5.4 HAL Allergy Immunotherapy Product Portfolio
6.5.5 HAL Recent Developments/Updates
6.6 Holister Stier
6.6.1 Holister Stier Company Information
6.6.2 Holister Stier Description and Business Overview
6.6.3 Holister Stier Allergy Immunotherapy Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Holister Stier Allergy Immunotherapy Product Portfolio
6.6.5 Holister Stier Recent Developments/Updates
6.7 Leti
6.7.1 Leti Company Information
6.7.2 Leti Description and Business Overview
6.7.3 Leti Allergy Immunotherapy Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Leti Allergy Immunotherapy Product Portfolio
6.7.5 Leti Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Allergy Immunotherapy Industry Chain Analysis
7.2 Allergy Immunotherapy Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Allergy Immunotherapy Production Mode & Process Analysis
7.4 Allergy Immunotherapy Sales and Marketing
7.4.1 Allergy Immunotherapy Sales Channels
7.4.2 Allergy Immunotherapy Distributors
7.5 Allergy Immunotherapy Customer Analysis
8 Allergy Immunotherapy Market Dynamics
8.1 Allergy Immunotherapy Industry Trends
8.2 Allergy Immunotherapy Market Drivers
8.3 Allergy Immunotherapy Market Challenges
8.4 Allergy Immunotherapy Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of TablesList of Tables
Table 1. Global Allergy Immunotherapy Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
Table 2. Global Allergy Immunotherapy Market Value by Application (2024 VS 2031) & (US$ Million)
Table 3. Global Allergy Immunotherapy Market Competitive Situation by Manufacturers in 2024
Table 4. Global Allergy Immunotherapy Sales (K Units) of Key Manufacturers (2020-2025)
Table 5. Global Allergy Immunotherapy Sales Market Share by Manufacturers (2020-2025)
Table 6. Global Allergy Immunotherapy Revenue (US$ Million) by Manufacturers (2020-2025)
Table 7. Global Allergy Immunotherapy Revenue Share by Manufacturers (2020-2025)
Table 8. Global Market Allergy Immunotherapy Average Price (USD/Unit) of Key Manufacturers (2020-2025)
Table 9. Global Key Players of Allergy Immunotherapy, Industry Ranking, 2022 VS 2023 VS 2024
Table 10. Global Key Manufacturers of Allergy Immunotherapy, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Allergy Immunotherapy, Product Type & Application
Table 12. Global Key Manufacturers of Allergy Immunotherapy, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Allergy Immunotherapy by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Allergy Immunotherapy as of 2024)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 17. Global Allergy Immunotherapy Sales by Region (2020-2025) & (K Units)
Table 18. Global Allergy Immunotherapy Sales Market Share by Region (2020-2025)
Table 19. Global Allergy Immunotherapy Sales by Region (2026-2031) & (K Units)
Table 20. Global Allergy Immunotherapy Sales Market Share by Region (2026-2031)
Table 21. Global Allergy Immunotherapy Revenue by Region (2020-2025) & (US$ Million)
Table 22. Global Allergy Immunotherapy Revenue Market Share by Region (2020-2025)
Table 23. Global Allergy Immunotherapy Revenue by Region (2026-2031) & (US$ Million)
Table 24. Global Allergy Immunotherapy Revenue Market Share by Region (2026-2031)
Table 25. North America Allergy Immunotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 26. North America Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 27. North America Allergy Immunotherapy Sales by Country (2026-2031) & (K Units)
Table 28. North America Allergy Immunotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 29. North America Allergy Immunotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 30. Europe Allergy Immunotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 31. Europe Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 32. Europe Allergy Immunotherapy Sales by Country (2026-2031) & (K Units)
Table 33. Europe Allergy Immunotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 34. Europe Allergy Immunotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 35. Asia Pacific Allergy Immunotherapy Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
Table 36. Asia Pacific Allergy Immunotherapy Sales by Region (2020-2025) & (K Units)
Table 37. Asia Pacific Allergy Immunotherapy Sales by Region (2026-2031) & (K Units)
Table 38. Asia Pacific Allergy Immunotherapy Revenue by Region (2020-2025) & (US$ Million)
Table 39. Asia Pacific Allergy Immunotherapy Revenue by Region (2026-2031) & (US$ Million)
Table 40. Latin America Allergy Immunotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 41. Latin America Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 42. Latin America Allergy Immunotherapy Sales by Country (2026-2031) & (K Units)
Table 43. Latin America Allergy Immunotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 44. Latin America Allergy Immunotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 45. Middle East and Africa Allergy Immunotherapy Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
Table 46. Middle East and Africa Allergy Immunotherapy Sales by Country (2020-2025) & (K Units)
Table 47. Middle East and Africa Allergy Immunotherapy Sales by Country (2026-2031) & (K Units)
Table 48. Middle East and Africa Allergy Immunotherapy Revenue by Country (2020-2025) & (US$ Million)
Table 49. Middle East and Africa Allergy Immunotherapy Revenue by Country (2026-2031) & (US$ Million)
Table 50. Global Allergy Immunotherapy Sales (K Units) by Type (2020-2025)
Table 51. Global Allergy Immunotherapy Sales (K Units) by Type (2026-2031)
Table 52. Global Allergy Immunotherapy Sales Market Share by Type (2020-2025)
Table 53. Global Allergy Immunotherapy Sales Market Share by Type (2026-2031)
Table 54. Global Allergy Immunotherapy Revenue (US$ Million) by Type (2020-2025)
Table 55. Global Allergy Immunotherapy Revenue (US$ Million) by Type (2026-2031)
Table 56. Global Allergy Immunotherapy Revenue Market Share by Type (2020-2025)
Table 57. Global Allergy Immunotherapy Revenue Market Share by Type (2026-2031)
Table 58. Global Allergy Immunotherapy Price (USD/Unit) by Type (2020-2025)
Table 59. Global Allergy Immunotherapy Price (USD/Unit) by Type (2026-2031)
Table 60. Global Allergy Immunotherapy Sales (K Units) by Application (2020-2025)
Table 61. Global Allergy Immunotherapy Sales (K Units) by Application (2026-2031)
Table 62. Global Allergy Immunotherapy Sales Market Share by Application (2020-2025)
Table 63. Global Allergy Immunotherapy Sales Market Share by Application (2026-2031)
Table 64. Global Allergy Immunotherapy Revenue (US$ Million) by Application (2020-2025)
Table 65. Global Allergy Immunotherapy Revenue (US$ Million) by Application (2026-2031)
Table 66. Global Allergy Immunotherapy Revenue Market Share by Application (2020-2025)
Table 67. Global Allergy Immunotherapy Revenue Market Share by Application (2026-2031)
Table 68. Global Allergy Immunotherapy Price (USD/Unit) by Application (2020-2025)
Table 69. Global Allergy Immunotherapy Price (USD/Unit) by Application (2026-2031)
Table 70. ALK-Abello Company Information
Table 71. ALK-Abello Description and Business Overview
Table 72. ALK-Abello Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 73. ALK-Abello Allergy Immunotherapy Product
Table 74. ALK-Abello Recent Developments/Updates
Table 75. Stallergenes Greer Company Information
Table 76. Stallergenes Greer Description and Business Overview
Table 77. Stallergenes Greer Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 78. Stallergenes Greer Allergy Immunotherapy Product
Table 79. Stallergenes Greer Recent Developments/Updates
Table 80. Merck Company Information
Table 81. Merck Description and Business Overview
Table 82. Merck Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 83. Merck Allergy Immunotherapy Product
Table 84. Merck Recent Developments/Updates
Table 85. Allergy Therapeutics Company Information
Table 86. Allergy Therapeutics Description and Business Overview
Table 87. Allergy Therapeutics Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 88. Allergy Therapeutics Allergy Immunotherapy Product
Table 89. Allergy Therapeutics Recent Developments/Updates
Table 90. HAL Company Information
Table 91. HAL Description and Business Overview
Table 92. HAL Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 93. HAL Allergy Immunotherapy Product
Table 94. HAL Recent Developments/Updates
Table 95. Holister Stier Company Information
Table 96. Holister Stier Description and Business Overview
Table 97. Holister Stier Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 98. Holister Stier Allergy Immunotherapy Product
Table 99. Holister Stier Recent Developments/Updates
Table 100. Leti Company Information
Table 101. Leti Description and Business Overview
Table 102. Leti Allergy Immunotherapy Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2020-2025)
Table 103. Leti Allergy Immunotherapy Product
Table 104. Leti Recent Developments/Updates
Table 105. Key Raw Materials Lists
Table 106. Raw Materials Key Suppliers Lists
Table 107. Allergy Immunotherapy Distributors List
Table 108. Allergy Immunotherapy Customers List
Table 109. Allergy Immunotherapy Market Trends
Table 110. Allergy Immunotherapy Market Drivers
Table 111. Allergy Immunotherapy Market Challenges
Table 112. Allergy Immunotherapy Market Restraints
Table 113. Research Programs/Design for This Report
Table 114. Key Data Information from Secondary Sources
Table 115. Key Data Information from Primary Sources
Table 116. Authors List of This Report
List of Figures
Figure 1. Product Picture of Allergy Immunotherapy
Figure 2. Global Allergy Immunotherapy Market Value Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Allergy Immunotherapy Market Share by Type: 2024 & 2031
Figure 4. Subcutaneous Immunotherapy Product Picture
Figure 5. Sublingual Immunotherapy Product Picture
Figure 6. Global Allergy Immunotherapy Market Value by Application (2020-2031) & (US$ Million)
Figure 7. Global Allergy Immunotherapy Market Share by Application: 2024 & 2031
Figure 8. Allergic Rhinitis
Figure 9. Allergic Asthma
Figure 10. Others
Figure 11. Global Allergy Immunotherapy Revenue, (US$ Million), 2020 VS 2024 VS 2031
Figure 12. Global Allergy Immunotherapy Market Size (2020-2031) & (US$ Million)
Figure 13. Global Allergy Immunotherapy Sales (2020-2031) & (K Units)
Figure 14. Global Allergy Immunotherapy Average Price (USD/Unit) & (2020-2031)
Figure 15. Allergy Immunotherapy Report Years Considered
Figure 16. Allergy Immunotherapy Sales Share by Manufacturers in 2024
Figure 17. Global Allergy Immunotherapy Revenue Share by Manufacturers in 2024
Figure 18. Global 5 and 10 Largest Allergy Immunotherapy Players: Market Share by Revenue in Allergy Immunotherapy in 2024
Figure 19. Allergy Immunotherapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
Figure 20. Global Allergy Immunotherapy Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Figure 21. North America Allergy Immunotherapy Sales Market Share by Country (2020-2031)
Figure 22. North America Allergy Immunotherapy Revenue Market Share by Country (2020-2031)
Figure 23. Europe Allergy Immunotherapy Sales Market Share by Country (2020-2031)
Figure 24. Europe Allergy Immunotherapy Revenue Market Share by Country (2020-2031)
Figure 25. Germany Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 26. France Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 27. U.K. Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 28. Italy Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 29. Russia Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 30. Asia Pacific Allergy Immunotherapy Sales Market Share by Region (2020-2031)
Figure 31. Asia Pacific Allergy Immunotherapy Revenue Market Share by Region (2020-2031)
Figure 32. China Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 33. Japan Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 34. South Korea Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 35. India Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 36. Australia Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 37. China Taiwan Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 38. Indonesia Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 39. Thailand Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 40. Malaysia Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 41. Latin America Allergy Immunotherapy Sales Market Share by Country (2020-2031)
Figure 42. Latin America Allergy Immunotherapy Revenue Market Share by Country (2020-2031)
Figure 43. Mexico Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 44. Brazil Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 45. Argentina Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 46. Middle East and Africa Allergy Immunotherapy Sales Market Share by Country (2020-2031)
Figure 47. Middle East and Africa Allergy Immunotherapy Revenue Market Share by Country (2020-2031)
Figure 48. Turkey Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 49. Saudi Arabia Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 50. UAE Allergy Immunotherapy Revenue Growth Rate (2020-2031) & (US$ Million)
Figure 51. Global Sales Market Share of Allergy Immunotherapy by Type (2020-2031)
Figure 52. Global Revenue Market Share of Allergy Immunotherapy by Type (2020-2031)
Figure 53. Global Allergy Immunotherapy Price (USD/Unit) by Type (2020-2031)
Figure 54. Global Sales Market Share of Allergy Immunotherapy by Application (2020-2031)
Figure 55. Global Revenue Market Share of Allergy Immunotherapy by Application (2020-2031)
Figure 56. Global Allergy Immunotherapy Price (USD/Unit) by Application (2020-2031)
Figure 57. Allergy Immunotherapy Value Chain
Figure 58. Channels of Distribution (Direct Vs Distribution)
Figure 59. Bottom-up and Top-down Approaches for This Report
Figure 60. Data Triangulation
Figure 61. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
